CDC42 and androgen insensitivity syndrome: In conclusion, CDC42 correlates with disease severity, Th2 cells, Th17 cells, and their secreted cytokines, which also serve as a biomarker to constantly monitor disease progression and recurrence risk of patients with AIS.